A1166C POLYMORPHISM OF THE GENE FOR ANGIOTENSIN II RECEPTOR 1ST TYPE AND ENDOTHELIAL DYSFUNCTION IN MEN WITH A HISTORY OF MYOCARDIAL INFARCTION IN YOUNG AGE

QR Code

A1166C POLYMORPHISM OF THE GENE FOR ANGIOTENSIN II RECEPTOR 1ST TYPE AND ENDOTHELIAL DYSFUNCTION IN MEN WITH A HISTORY OF MYOCARDIAL INFARCTION IN YOUNG AGE

The renin-angiotensin-aldosterone system (RAAS) is involved in the pathogenesis of Coronary Heart Disease and myocardial infarction. The crucial component of the RAAS is angiotensin II and its effects are carried out by angiotensin II receptors 1st type (AT1R).Aim of the study: determine the inciden...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. A. Berkovich, E. A. Bazhenova, E. V. Volkova, M. Z. Alugishvili, N. V. Vahrameeva, I. O. Kiselev, E. V. Shlyahto, E. I. Schwarz
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2000-12-01
Series:	Российский кардиологический журнал
Subjects:	myocardial infarction polymorphism of the gene for angiotensin ii receptor 1st type endothelial dysfunction
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2199
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between A1166C Polymorphism of the Angiotensin II Type-1 Receptor Gene and Type-2 Diabetic Nephropathy in an Indonesian Malay Population
by: Zulkhair Ali, et al.
Published: (2019-01-01)

Association between A1166C Polymorphism of the Angiotensin II Type-1 Receptor Gene and Type-2 Diabetic Nephropathy in an Indonesian Malay Population
by: Zulkhair Ali, et al.
Published: (2019-01-01)

ANGIOTENSIN II AND MYOCARDIAL INFARCTION
by: O. P. Shevchenko, et al.
Published: (2016-01-01)

EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL
by: C. Ferrario
Published: (2010-12-01)

The role of the classical renin–angiotensin system and angiotensin-converting enzyme 2/Ang(1–7)/Mas axis in pulmonary fibrosis
by: Changhui Lang, et al.
Published: (2025-07-01)

Variation of Concentrations of Angiotensin II, AngiotensinConverting Enzyme and Matrix Metalloprotease-9 in Tears and Serum of Patients with Diabetic Retinopathy
by: V. V. Neroev, et al.
Published: (2020-12-01)

Association of insertion deletion polymorphism of the ACE gene with factors of circulating rennin-angiotensin-aldosterone system and endothelial function of skin microvassals in preeclampsia
by: O. V. Radkov, et al.
Published: (2011-08-01)

ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-07-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

ANGIOTENSIN II RECEPTOR TYPE 1 EXPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS
by: I. S. Mykhailichenko
Published: (2016-04-01)

PROGNOSTIC ROLE OF A1166C POLYMORPHISMS OF THE ANGIOTENSINE II RECEPTOR GENE (AGT2R1) IN CORONARY ATHEROSCLEROSIS AMONG ADYGHEA REPUBLIC INHABITANTS
by: T. M. Ashkanova, et al.
Published: (2015-10-01)

Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01)

Angiotensin Receptor Blockade Does Not Decrease Synthetic Angiotensin II (Giapreza<sup>®</sup>) Effectiveness in Perioperative Hypotension Surrounding Kidney Transplant
by: Natalie Pettit, et al.
Published: (2025-06-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

Developing approaches to treating arterial hypertension in regard to possible pathways of angiotensin II synthesis
by: N. M. Chikhladze, et al.
Published: (2006-04-01)

Angiotensin II and Cardiovascular Disease: Balancing Pathogenic and Protective Pathways
by: Ulvi Bayraktutan
Published: (2025-07-01)

Angioprotection role in arterial hypertension treatment: focus on olmesartan
by: D. V. Nebieridze, et al.
Published: (2012-10-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors
by: R. D. Smith, et al.
Published: (2010-12-01)

High-Intensity Aerobic Exercise Prevents Angiotensin II-Induced Muscle Atrophy
by: Jong-Hwa Won, et al.
Published: (2025-07-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01)

IS IT WORTH TO DISCONTINUE DRUGS BLOCKING THE ACTIVITY OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE PERI-OPERATIVE PERIOD?
by: V. V. Lomivorotov, et al.
Published: (2018-07-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

Endothelial functional activity and circadian blood pressure dynamics in hypertensive patients treated with angiotensin receptor antagonists
by: N. G. Poteshkina, et al.
Published: (2011-10-01)

An angiotensin-converting enzyme inhibitor in the combination treatment of rheumatoid arthritis
by: E. B. Komarova, et al.
Published: (2017-09-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2012-09-01)

The evaluation of the relationship between anti angiotensin type I antibodies in hypertensive patients undergoing kidney transplantation
by: Senturk Ciftci Hayriye, et al.
Published: (2025-02-01)

ENDOTHELIAL DYSFUNCTION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME AND MULTIFOCAL ATHEROSCLEROSIS
by: S. A. Berns, et al.
Published: (2013-12-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
by: O. M. Drapkina, et al.
Published: (2020-07-01)

Association between renin-angiotensin system gene polymorphism and cardio-ankle vascular index in patients with COVID-19
by: V. I. Podzolkov, et al.
Published: (2024-12-01)

Expression of angiotensin II type 2 receptors and syndecan-1 in prostate cancer
by: E. A. Chernogubova, et al.
Published: (2024-11-01)

The Correlation Between Angiotensin II Levels and Homeostatic Model Assessment of Insulin Resistance in Normotensive Young Adults with a Family History of Essential Hypertension
by: Stella Palar, et al.
Published: (2025-07-01)

Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers?
by: V. V. Fomin, et al.
Published: (2007-06-01)

Effects of Angiotensin II Receptor 1 Inhibition by LCZ696 on the Acquisition and Relapse of Methamphetamine-Associated Contextual Memory
by: Xiaofang Li, et al.
Published: (2025-07-01)

The systemic angiotensin-II role in the development of retinopathy of prematurity
by: N. A. Osipova, et al.
Published: (2023-07-01)

BLOOD PRESSURE-LOWERING EFFICACY OF OLMESARTAN RELATIVE TO OTHER ANGIOTENSIN II RECEPTOR ANTAGONISTS: AN OVERVIEW OF RANDOMIZED CONTROLLED STUDIES
by: Faiez Zannad, et al.
Published: (2010-08-01)

Angiotensin II and COVID-19. Secrets of interactions
by: A. O. Konradi, et al.
Published: (2020-05-01)

AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
by: L. L. Kirichenko, et al.
Published: (2014-02-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS
by: V. V. Fomin
Published: (2016-01-01)